|
22 -> 22
|
Y
|
UniProt: Nearly wild-type spacer acquisition in vivo..
|
|
41 -> 41
|
R
|
UniProt: Dramatically decreased spacer acquisition in vivo..
|
|
59 -> 59
|
R
|
UniProt: Dramatically decreased spacer acquisition in vitro, 250-fold decreased affinity for protospacer DNA..
|
|
66 -> 66
|
R
|
UniProt: Dramatically decreased spacer acquisition in vitro, 250-fold decreased affinity for protospacer DNA..
|
|
84 -> 84
|
R
|
UniProt: Dramatically decreased spacer acquisition in vivo..
|
|
96 -> 278
|
SDKLLYQAKLALDEDLRLKVVRKMFELRFGEPAPARRSVEQLRGIEGSRVRATYALLAKQYGVTWNGRRYDPKDWEKGDTINQCISAATSCLYGVTEAAILAAGYAPAIGFVHTGKPLSFVYDIADIIKFDTVVPKAFEIARRNPGEPDREVRLACRDIFRSSKTLAKLIPLIEDVLAAGEIQ
|
UniProt: Sufficient for cleavage of ssRNA, ssDNA and Holliday junction DNA; Sequence Annotation Type: region of interest.
|
|
130 -> 228
|
ARRSVEQLRGIEGSRVRATYALLAKQYGVTWNGRRYDPKDWEKGDTINQCISAATSCLYGVTEAAILAAGYAPAIGFVHTGKPLSFVYDIADIIKFDTV
|
|
|
141 -> 141
|
E
|
E141A abolished nuclease activity |CITS: [21219465]|.
|
|
149 -> 149
|
Y
|
UniProt: No effect on in vitro protospacer integration..
|
|
165 -> 165
|
Y
|
UniProt: No effect on in vitro protospacer integration (PubMed:25707795). Alone significantly decreased protospacer acquisition in vivo (PubMed:26478180). Loss of protospacer acquisition, decreased protospacer binding; in association with A-170, significantly decreased protospacer binding; in association with A-217 (PubMed:26478180)..
|
|
170 -> 170
|
W
|
UniProt: Alone significantly decreased protospacer acquisition in vivo (PubMed:26478180). Decreased protospacer binding; in association with A-170 (PubMed:26478180)..
|
|
184 -> 184
|
T
|
UniProt: No cleavage of any substrates..
|
|
188 -> 188
|
Y
|
UniProt: Partial inhibition of cleavage (PubMed:21219465). No effect on in vitro protospacer integration (PubMed:25707795). Significantly decreased protospacer acquisition in vivo (PubMed:26478180)..
|
|
208 -> 208
|
H
|
H208A abolished nuclease activity |CITS: [21219465]|.
|
|
211 -> 211
|
K
|
UniProt: No cleavage of any substrates..
|
|
217 -> 217
|
Y
|
UniProt: No effect on in vitro protospacer integration (PubMed:25707795). Alone significantly decreased protospacer acquisition in vivo (PubMed:26478180). Significantly decreased protospacer binding; in association with A-165 (PubMed:26478180)..
|
|
218 -> 218
|
D
|
UniProt: No cleavage of any substrates, no restoration of UV or MMC resistance (PubMed:21219465). Loss of spacer acquisition in vivo (PubMed:24793649)..
|
|
221 -> 221
|
D
|
D221A abolished nuclease activity |CITS: [21219465]|.
|
|
224 -> 224
|
K
|
UniProt: No cleavage of any substrates (PubMed:21219465). Loss of spacer acquisition in vivo (PubMed:24793649, PubMed:25707795)..
|
|
245 -> 245
|
R
|
UniProt: No effect on spacer acquisition..
|
|
248 -> 248
|
R
|
UniProt: Dramatically decreased spacer acquisition in vivo..
|
|
252 -> 252
|
R
|
UniProt: No effect on spacer acquisition..
|
|
256 -> 256
|
R
|
UniProt: No effect on spacer acquisition..
|
|
278 -> 305
|
QPPAPPEDAQPVAIPLPVSLGDAGHRSS
|
UniProt: Disordered; Sequence Annotation Type: region of interest.
|
|
282 -> 305
|
PPEDAQPVAIPLPVSLGDAGHRSS
|
UniProt: No effect on spacer acquisition, Cas1-Cas2 complex formation or CRISPR DNA-binding by complex..
|
|
291 -> 291
|
I
|
UniProt: No effect on spacer acquisition..
|